Study of the Safety, Tolerability, and Pharmacokinetics of GAP-134 Administered Intravenously

NCT00783341 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: GAP-134
DRUG: placebo

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer